Course of Selenoprotein-Related Myopathies
The clinical course and genotype-phenotype correlations in 41 patients aged 1-60 years with selenoprotein-related myopathy (SEPNRM) due to SEPN1 gene mutations were evaluated retrospectively in a study at The Dubowitz Neuromuscular Center, London, and other centers in the UK.
Main Author: | J Gordon Millichap |
---|---|
Format: | Article |
Language: | English |
Published: |
Pediatric Neurology Briefs Publishers
2011-08-01
|
Series: | Pediatric Neurology Briefs |
Subjects: | |
Online Access: | https://www.pediatricneurologybriefs.com/articles/664 |
Similar Items
-
Nemaline Myopathy
by: J Gordon Millichap
Published: (1988-11-01) -
Respiratory treatment in a patient with nemaline myopathy
by: Massimiliano Polastri, et al.
Published: (2019-12-01) -
Recovery from hypoxemia and Hypercapnia following noninvasive pressure support ventilation in a patient with statin-associated necrotizing myopathy: a case report
by: Yuriko Yamamura, et al.
Published: (2020-06-01) -
Chloroquine and Hydroxychloroquine Myopathy: Clinical Spectrum and Treatment Outcomes
by: Elie Naddaf, et al.
Published: (2021-02-01) -
Immune-Mediated Necrotizing Myopathy: An Often Misdiagnosed Entity
by: Joana Almeida Espírito Santo, et al.
Published: (2015-01-01)